Improved quality control of [177Lu]Lu-PSMA I&T
Abstract Background Targeted radionuclide therapy with [177Lu]Lu-PSMA I&T (zadavotide guraxetan) has proven high efficacy and safety in treating patients with advanced prostate cancer worldwide. Several methods to determine the radiochemical purity have been reported but also limitations in the HPLC...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
SpringerOpen
2023-03-01
|
| Colección: | EJNMMI Radiopharmacy and Chemistry |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1186/s41181-023-00191-6 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|